SCHEMBL22563550

SCHEMBL22563550

N#Cc1c(-n2c3ccc(-n4c5ccccc5c5ccccc54)cc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)cc(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)cc1-n1c2ccc(-n3c4ccccc4c4ccccc43)cc2c2cc(-n3c4ccccc4c4ccccc43)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 5/20 0.40
L3MBTL1 Q9Y468 5/20 0.39
ADORA1 P30542 3/20 0.39
ADORA2A P29274 2/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 4/20 0.36
ATM Q13315 1/20 0.36
HPGD P15428 5/20 0.35
LMNA P02545 3/20 0.35
KMT2A Q03164 3/20 0.35
NPSR1 Q6W5P4 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
CHEK1 O14757 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22563492 1.00 SQOR (0.40) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL21278834 0.97 SQOR (0.39) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL21279049 0.97 SQOR (0.39) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL19942763 0.93 HSD17B10 (0.37) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL21109714 0.93 HSD17B10 (0.37) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL31273800 0.93 SQOR (0.45) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL22563375 0.93 SQOR (0.45) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL19909189 0.92 SQOR (0.40) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL19913311 0.92 SQOR (0.40) SQORL3MBTL1ADORA1ADORA2AMAPK1
SCHEMBL22563547 0.91 SQOR (0.40) SQORL3MBTL1ADORA1ADORA2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 SQOR 412/4885L3MBTL1 3665/4885ADORA1 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.